Aevi Genomic Medicine Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of AEVI-001 in 22q Deletion Syndrome
Inova Translational Medicine Institute Partners with Translational Software on MediMap™, an Optional Newborn Pharmacogenomic Test at Inova Women’s Hospital
Eastern Metals Recommences ASX Trading – Aiming to Unlock High-Potential Copper Discoveries in New Brunswick, Canada
